Provided by Tiger Trade Technology Pte. Ltd.

Nuveen Minnesota Municipal Income Fund

11.88
-0.1200-1.00%
Post-market: 11.880.00000.00%16:10 EDT
Volume:17.44K
Turnover:207.90K
Market Cap:75.04M
PE:11.65
High:12.09
Open:12.00
Low:11.82
Close:12.00
52wk High:12.25
52wk Low:11.07
Shares:6.32M
Float Shares:6.08M
Volume Ratio:1.08
T/O Rate:0.29%
Dividend:0.83
Dividend Rate:7.01%
EPS(TTM):1.02
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Nuveen Minnesota Quality Municipal Income Fund Announces Annual Shareholder Meeting

Reuters
·
Mar 04

Nuveen Minnesota Quality Municipal Income Fund Declares $0.0665 Monthly Distribution

Reuters
·
Feb 28

Nuveen Minnesota Quality Municipal Income Fund Files Initial Beneficial Ownership Statement for EVP, Chief Risk & Compliance Joseph Castro

Reuters
·
Feb 24

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

GlobeNewswire
·
Feb 23

Blue Ocean Technologies Announces Executive Changes

prnewswire
·
Feb 09

Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution

Reuters
·
Jan 31

Nuveen Minnesota Quality Municipal Income Fund Issues Monthly Distribution Notice

Reuters
·
Jan 01

The National Museum of Singapore honours the nation's 60th anniversary with two new experiences to introduce Singapore's evolving story

prnewswire
·
Dec 19, 2025

Press Release: Evoke Pharma and QOL Medical Announce Expiration of Tender Offer

Dow Jones
·
Dec 17, 2025

Nuveen Minnesota Quality Municipal Income Fund Announces Monthly Distribution

Reuters
·
Nov 29, 2025

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

GlobeNewswire
·
Nov 08, 2025

Cboe’s exit shows Australia needs Regulation NMS

LiveWire
·
Nov 06, 2025

Nuveen Minnesota Quality Municipal Income Fund Files Initial Beneficial Ownership Statement for VP and Treasurer Robert Tanner Page

Reuters
·
Nov 04, 2025

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

GlobeNewswire
·
Oct 11, 2025

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

GlobeNewswire
·
Sep 21, 2025

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

GlobeNewswire
·
Sep 21, 2025

Gilat Satellite announces AI transformation of its NMS integrated MCP

TIPRANKS
·
Sep 11, 2025

Gilat Becomes First to Market with AI-Powered Network Management System

GlobeNewswire
·
Sep 11, 2025